FDA approves Wezlana for multiple inflammatory diseases
Nov 02, 2023
Approval of the biosimilar allows for interchangeable use with Stelara in both adult and pediatric patients
Oral switch noninferior for low-risk S. Aureus bloodstream infection
Jan 26, 2024
Early oral antimicrobial therapy was noninferior to intravenous standard therapy for low-risk bloodstream infection.
Hospital-onset SARS-CoV-2 infection during omicron linked to morbidity
Jul 15, 2024
Hospital-onset SARS-CoV-2 remained associated with increased morbidity and mortality during the omicron era.
Eye ointments sold at Walmart, CVS recalled due to infection risk
Feb 27, 2024
Eye ointment products made in India and sold in the United States at Walmart, CVS and other retailers are being recalled due to a danger of infection.
More eye drops recalled due to infection danger
Nov 02, 2023
The new recall affects certain LEADER brand eye drops; the FDA says it found unsanitary conditions in a facility where they are manufactured.
FDA warns eye drops from major brands may cause infection
Oct 30, 2023
Twenty-six products can cause eye infection and blindness, an advisory warns.
ACP: Next-generation antibiotics underused for gram-negative infections
Apr 22, 2024
41.5% of difficult-to-treat resistance episodes were treated exclusively with traditional agents.
Federal final rule drops bring cries of ‘flawed,’ ‘aggressive,’ ‘dramatic’ from senior living...
By
Kimberly Bonvissuto
Apr 25, 2024
Late April brought a shower of regulatory changes as the federal government dropped four major final rules this week that the senior living and care industry is calling “flawed,” “aggressive” and...
Neurological, neuropsychiatric symptoms common in COVID-19
Jun 10, 2021
Symptoms with the highest prevalence included anosmia, weakness, fatigue, dysgeusia, myalgia, and depression.
FDA approves new antibiotic for three indications
Apr 08, 2024
Zevtera is approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections and bacterial pneumonia.